Elevance Health Inc. (ELV) reported Q3 EPS of $7.53, $0.37 better than the analyst estimate of $7.16. Revenue for the quarter came in at $39.6 billion versus the consensus estimate of $39.26 billion.
GUIDANCE:
Elevance Health Inc. sees FY2022 EPS of $28.95.